Stoke Therapeutics, Inc. ($STOK)
Allan Jonathan โ GENERAL COUNSEL & CORP SEC
Shares
1,791
Price
$33.38
Total Value
$59,775.34
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Mar 24, 2026
EPS:Est: -0.93
Revenue:Est: $6.24M
Transaction Details
| Insider | Allan Jonathan |
|---|---|
| Title | GENERAL COUNSEL & CORP SEC |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 1,791 |
| Price per Share | $33.38 |
| Total Value | $59,775.34 |
| Shares Owned After | 33,464 |
| Derivative | No |
| Accession Number | 0001966716-26-000006 |
| Document | View SEC Filing |